Dr. rer. nat. Marianne Kraus
Syringolin A selectively labels the 20 S proteasome in murine EL4 and wild-type and bortezomib-adapted leukaemic cell lines
Clerc J, Overkleeft H, Driessen C, Dudler R, Bachmann A, Huber R, Groll M, Kraus M, Florea B, Kaiser M. Syringolin A selectively labels the 20 S proteasome in murine EL4 and wild-type and bortezomib-adapted leukaemic cell lines. Chembiochem : a European journal of chemical biology 2009; 10:2638-43.
Nov 2, 2009Syringolin A selectively labels the 20 S proteasome in murine EL4 and wild-type and bortezomib-adapted leukaemic cell lines
Nov 2, 2009Chembiochem : a European journal of chemical biology 2009; 10:2638-43
Clerc Jérôme, Overkleeft Herman S, Driessen Christoph, Dudler Robert, Bachmann André S, Huber Robert, Groll Michael, Kraus Marianne, Florea Bogdan I, Kaiser Markus
HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase
Harman A, Driessen C, Slobedman B, Stern J, Nasr N, Mercier S, Tang O, Turville S, Byth K, Bye C, Kraus M, Cunningham A. HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase. Blood 2009; 114:85-94.
Jul 2, 2009HIV-1-infected dendritic cells show 2 phases of gene expression changes, with lysosomal enzyme activity decreased during the second phase
Jul 2, 2009Blood 2009; 114:85-94
Harman Andrew N, Driessen Christoph, Slobedman Barry, Stern Josh L, Nasr Najla, Mercier Sarah K, Tang Owen, Turville Stuart G, Byth Karen, Bye Chris R, Kraus Marianne, Cunningham Anthony L
Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells
Rückrich T, Kraus M, Gogel J, Beck A, Ovaa H, Verdoes M, Overkleeft H, Kalbacher H, Driessen C. Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009; 23:1098-105.
Jun 1, 2009Characterization of the ubiquitin-proteasome system in bortezomib-adapted cells
Jun 1, 2009Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009; 23:1098-105
Rückrich T, Kraus Marianne, Gogel J, Beck A, Ovaa H, Verdoes M, Overkleeft H S, Kalbacher H, Driessen Christoph
Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation
Fissolo N, Kraus M, Reich M, Ayturan M, Overkleeft H, Driessen C, Weissert R. Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation. European journal of immunology 2008; 38:2401-11.
Sep 1, 2008Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation
Sep 1, 2008European journal of immunology 2008; 38:2401-11
Fissolo Nicolas, Kraus Marianne, Reich Michael, Ayturan Miriam, Overkleeft Herman, Driessen Christoph, Weissert Robert
Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis
Kraus M, Hartmann J, Koscielniak E, Ovaa H, Overkleeft H, Rückrich T, Müller H, Gogel J, Malenke E, Driessen C. Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis. Molecular cancer therapeutics 2008; 7:1940-8.
Jul 1, 2008Ritonavir induces endoplasmic reticulum stress and sensitizes sarcoma cells toward bortezomib-induced apoptosis
Jul 1, 2008Molecular cancer therapeutics 2008; 7:1940-8
Kraus Marianne, Hartmann Jörg Thomas, Koscielniak Ewa, Ovaa Huib, Overkleeft Herman, Rückrich Thomas, Müller Holger, Gogel Jeannette, Malenke Elke, Driessen Christoph
Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits
Busse A, Kraus M, Na I, Rietz A, Scheibenbogen C, Driessen C, Blau I, Thiel E, Keilholz U. Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits. Cancer 2008; 112:659-70.
Feb 1, 2008Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits
Feb 1, 2008Cancer 2008; 112:659-70
Busse Antonia, Kraus Marianne, Na Il-Kang, Rietz Anika, Scheibenbogen Carmen, Driessen Christoph, Blau Igor Wolfgang, Thiel Eckhard, Keilholz Ulrich
Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins
Reich M, van Swieten P, Sommandas V, Kraus M, Fischer R, Weber E, Kalbacher H, Overkleeft H, Driessen C. Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins. Journal of leukocyte biology 2007; 81:990-1001.
Apr 1, 2007Endocytosis targets exogenous material selectively to cathepsin S in live human dendritic cells, while cell-penetrating peptides mediate nonselective transport to cysteine cathepsins
Apr 1, 2007Journal of leukocyte biology 2007; 81:990-1001
Reich Michael, van Swieten Paul F, Sommandas Vinod, Kraus Marianne, Fischer Rainer, Weber Ekkehard, Kalbacher Hubert, Overkleeft Herman S, Driessen Christoph
Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells
Kraus M, Ovaa H, Overkleeft H, Burg D, Berkers C, Kammer W, Beck A, Gogel J, Reich M, Rückrich T, Driessen C. Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007; 21:84-92.
Jan 1, 2007Activity patterns of proteasome subunits reflect bortezomib sensitivity of hematologic malignancies and are variable in primary human leukemia cells
Jan 1, 2007Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007; 21:84-92
Kraus Marianne, Ovaa H, Overkleeft H, Burg D, Berkers C R, Kammer W, Beck A, Gogel J, Reich M, Rückrich T, Driessen Christoph
Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells
Burster T, Overkleeft H, Weber E, Häring H, Kalbacher H, Kraus M, Reich M, Weissert R, Schnorrer P, Tolosa E, Beck A, Driessen C. Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells. Journal of immunology (Baltimore, Md. : 1950) 2005; 175:5940-9.
Nov 1, 2005Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells
Nov 1, 2005Journal of immunology (Baltimore, Md. : 1950) 2005; 175:5940-9
Burster Timo, Overkleeft Herman, Weber Ekkehard, Häring Hans-Ulrich, Kalbacher Hubert, Kraus Marianne, Reich Michael, Weissert Robert, Schnorrer Petra, Tolosa Eva, Beck Alexander, Driessen Christoph
Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity
van Zutphen S, Kraus M, Driessen C, van der Marel G, Overkleeft H, Reedijk J. Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity. Journal of inorganic biochemistry 2005; 99:1384-9.
Jun 1, 2005Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity
Jun 1, 2005Journal of inorganic biochemistry 2005; 99:1384-9
van Zutphen Steven, Kraus Marianne, Driessen Christoph, van der Marel Gijs A, Overkleeft Herman S, Reedijk Jan
Autophagy promotes MHC class II presentation of peptides from intracellular source proteins
Dengjel J, Rammensee H, Driessen C, Brock R, Kalbacher H, Brandenburg J, Altenberend F, Kreymborg K, Müller M, Kraus M, Reich M, Fischer R, Schoor O, Stevanovic S. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proceedings of the National Academy of Sciences of the United States of America 2005; 102:7922-7.
May 31, 2005Autophagy promotes MHC class II presentation of peptides from intracellular source proteins
May 31, 2005Proceedings of the National Academy of Sciences of the United States of America 2005; 102:7922-7
Dengjel Jörn, Rammensee Hans-Georg, Driessen Christoph, Brock Roland, Kalbacher Hubert, Brandenburg Jens, Altenberend Florian, Kreymborg Katharina, Müller Margret, Kraus Marianne, Reich Michael, Fischer Rainer, Schoor Oliver, Stevanovic Stefan
Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner
Lautwein A, Nordheim A, Kalbacher H, Weber E, Kammer W, Schwarz G, Overkleeft H, Brandenburg J, Burster T, Reich M, Kraus M, Driessen C. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner. Journal of leukocyte biology 2004; 75:844-55.
May 1, 2004Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner
May 1, 2004Journal of leukocyte biology 2004; 75:844-55
Lautwein Alfred, Nordheim Alfred, Kalbacher Hubert, Weber Ekkehard, Kammer Winfried, Schwarz Gerold, Overkleeft Herman S, Brandenburg J, Burster Timo, Reich Michael, Kraus Marianne, Driessen Christoph